Skip to content
Find a Provider
Jane Larae Liesveld, M.D.

Jane Larae Liesveld, M.D.

Hematology & Oncology , Cancer

5 out of 5 stars
402 Ratings
49 Comments
UR Medicine Faculty The University of Rochester Medical Faculty Group (URMFG) consists of over 900 specialist and primary care providers spanning 19 departments. URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner Accountable Health Partners (AHP) is a network of over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the region. AHP offers a full range of care.
Accepting New Patients

Contact

Appointment (585) 275-5823
Fax (585) 273-1051

About Me

While the doctor-patient relationship is one of potential intensity and privacy, the best patient care comes from teamwork, which values all who contribute to achieving high-quality care with compassion. Providing patients and their families with the knowledge and means to be partners in care is one...
While the doctor-patient relationship is one of potential intensity and privacy, the best patient care comes from teamwork, which values all who contribute to achieving high-quality care with compassion. Providing patients and their families with the knowledge and means to be partners in care is one of my key roles as a physician.

When a patient is diagnosed with a blood cancer or chronic blood condition, it is often the start of a new journey that will be the beginning of great change. Walking with patients through this journey from start to finish, and offering therapy and guidance along the way, is a source of professional and personal satisfaction for me. Hematology/oncology is a field where clinical and basic research can be rapidly applied to improve outcomes and quality of life.

I grew up in the Midwest, but have lived in Rochester since I began my post-doctoral medical training. My association with Strong, the University of Rochester and the people in our community and surrounding areas has enriched my life. I feel privileged to work in such a wonderful environment. I have expertise in novel therapies for acute myeloid leukemia, stem cell mobilization and homing, as well as stem cell transplantation.

Conditions I Treat

- Leukemia, all types
- Myeloproliferative disorders
- Myelodysplastic syndromes
- Multiple myeloma
- Stem cell transplantation

Certified Specialties

Hematology - American Board of Internal Medicine

Internal Medicine - American Board of Internal Medicine

Medical Oncology - American Board of Internal Medicine

Faculty Appointments

Professor - Department of Medicine, Hematology/Oncology (SMD)

Credentials

Residency & Fellowship

Fellowship, Research, University of Rochester Medical Center. 1988 - 1989

Fellowship, Medical Oncology, University of Rochester Medical Center. 1987 - 1988

Fellowship, Hematology, University of Rochester Medical Center. 1984 - 1987

Residency, Internal Medicine, University of Rochester Medical Center. 1981 - 1984

Internship, Internal Medicine, University of Rochester Medical Center. 1980 - 1981

Education

MD | University Of Iowa Roy J & Lucille A Carver College Of Medicine. 1980

Awards

Gilda's Club of Rochester Jacob Gitelman Award. 2009

Hematology-Oncology Fellowship Teaching Award. 2007

Aplastic Anemia and MDS International Foundation Gordon Forgash Research Award. 2005 - 2007

Lawrence A. Kohn Senior Teaching Fellowship. 2004 - 2006

Leukemia Society of America, Clinical Scholar Award. 1998 - 2003

Leukemia Society of America Special Fellowship. 1989 - 1992

James P. Wilmot Postdoctoral Cancer Research Fellowship. 1989 - 1992

American Cancer Society Clinical Fellowship Award. 1987 - 1988

Research

Effects of oxygen metabolites/chemokines on hematopoietic stem cell expansion and preservation.

Effects of hematopoietic growth factors and inhibitors on AML blast proliferation (correlative clinical studies)

Effects of hematopoietic stem cell adhesion on marrow stromal cell cytokine p...
Effects of oxygen metabolites/chemokines on hematopoietic stem cell expansion and preservation.

Effects of hematopoietic growth factors and inhibitors on AML blast proliferation (correlative clinical studies)

Effects of hematopoietic stem cell adhesion on marrow stromal cell cytokine production.

Role of signal transduction inhibition in treatment of acute myelogenous leukemia/myelodysplasia.

Characterization of mobilized peripheral blood stem cells

Clinical Trials

A Phase III Randomized, Double-Blind Trial to Evaluate the Efficacy of Uproleselan Administered With Chemotherapy Versus Chemotherapy Alone in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Lead Researcher: Jane Larae Liesveld MD

The purpose of this trial is to compare overall survival achieved with uproleselan administered with chemotherapy versus chemotherapy alone.

A Program for Monitoring Minimal Residual Disease Following Treatment of Patients With Acute Myeloid Leukemia or High Grade Myelodysplastic Syndrome

Lead Researcher: Jane Larae Liesveld MD

This study is being performed to develop assays to determine the impact of the therapy patients receive for treatment of AML or MDS and to determine if these tests can identify those patients who are at a greater risk for having their disease relapse...

Patents

Continuous Flow Chamber Device for Separation, Concentration and/or Purification of Cells

Issue date: February 22, 2011

Patent #: 7,892,766

Country: United States

Inventors: Nichola Charles, Nathan Clark, John P Gentile, Michael R King, Jane Liesveld, Nipa Anand Mody

Publications

Journal Articles

Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR study.

Jain T, Estrada-Merly N, Salas MQ, Kim S, DeVos JD, Chen M, Fang X, Kumar R, Andrade-Campos M, Elmariah H, Agrawal V, Aljurf M, Bacher U, Badar T, Badawy SM, Ballen KK, Beitinjaneh A, Bhatt VR, Bredeson CN, DeFilipp Z, Dholaria B, Farhadfar N, Farhan S, Gandhi A, Ganguly S, Gergis U, Grunwald MR, Hamad N, Hamilton BK, Inamoto Y, Iqbal M, Jamy O, Juckett M, Kharfan-Dabaja MA, Krem MM, Lad DP, Liesveld JL, Al Malki MM, Malone AK, Murthy HS, Ortí G, Patel SS, Pawarode A, Perales MA, van der Poel MWM, Ringden O, Rizzieri DA, Rovo A, Savani BN, Savoie ML, Seo S, Solh MM, Ustun C, Verdonck LF, Wingard JR, Wirk B, Bejanyan N, Jones RJ, Nishihori T, Oran B, Nakamura R, Scott BL, Saber W, Gupta V

Blood advances.. 2024 August 278 (16):4281-4293. Epub 1900 01 01.

In silico predicted compound targeting the IQGAP1-GRD domain selectively inhibits growth of human acute myeloid leukemia.

Sahasrabudhe DM, Liesveld JL, Minhajuddin M, Singh NA, Nath S, Kumar VM, Balys M, Evans AG, Azadniv M, Hansen JN, Becker MW, Sharon A, Thomas VK, Moore RG, Khera MK, Jordan CT, Singh RK

Scientific reports.. 2024 June 414 (1):12868. Epub 06/04/2024.

Temporal Single Cell Analysis of Leukemia Microenvironment Identifies Taurine-Taurine Transporter Axis as a Key Regulator of Myeloid Leukemia.

Rodems BJ, Sharma S, Baker CD, Kaszuba CM, Ito T, Liesveld JL, Calvi LM, Becker MW, Jordan CT, Ashton JM, Bajaj J

bioRxiv : the preprint server for biology.. 2024 May 14 Epub 05/14/2024.

Diagnosing familial platelet disorder with predisposition to myeloid malignancy: Lessons learned from a germline whole-gene deletion of RUNX1.

Cliburn JA, Uy JC, Swift S, Liesveld JL, Iqbal MA, Jajosky AN, Becker MW

International journal of laboratory hematology.. 2024 February 46 (1):203-206. Epub 11/12/2023.

Response-adapted, time-limited venetoclax, umbralisib, and ublituximab for relapsed/refractory chronic lymphocytic leukemia.

Hill BT, Ma S, Zent CS, Baran AM, Wallace DS, Advani AS, Winter AM, Winter JN, Gordon LI, Karmali R, Liesveld JL, Mulford DA, Rowland C, Bui A, Sportelli P, Miskin HP, Weiss MS, Friedberg JW, Barr PM

Blood advances.. 2024 January 238 (2):378-387. Epub 1900 01 01.

Telehealth serious illness care program for older adults with hematologic malignancies: a single-arm pilot study.

Locastro M, Mortaz Hedjri S, Wang Y, Mendler JH, Norton SA, Bernacki R, Carroll T, Klepin HD, Liesveld JL, Huselton EJ, Kluger B, Loh KP

Blood advances.. 2023 December 267 (24):7597-7607. Epub 1900 01 01.

Use of tamibarotene, a potent and selective RAR? agonist, in combination with azacitidine in patients with relapsed and refractory AML with gene overexpression.

Stein EM, de Botton S, Cluzeau T, Pigneux A, Liesveld JL, Cook RJ, Rousselot P, Rizzieri DA, Braun T, Roboz GJ, Lebon D, Heiblig M, Baker K, Volkert A, Paul S, Rajagopal N, Roth DA, Kelly M, Peterlin P

Leukemia & lymphoma.. 2023 December 64 (12):1992-2001. Epub 08/12/2023.

A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis.

Tamari R, McLornan DP, Ahn KW, Estrada-Merly N, Hernandez-Boluda JC, Giralt SA, Palmer JM, Gale RP, DeFilipp Z, Marks D, van der Poel MWM, Verdonck LF, Battiwalla M, Díaz MA, Gupta V, Ali H, Litzow MR, Lazarus HM, Gergis U, Bashey A, Liesveld JL, Hashmi S, Pu JJ, Beitinjaneh A, Bredeson CN, Rizzieri DA, Savani BN, Abid MB, Ganguly S, Agrawal V, Ulrike V, Wirk B, Jain T, Cutler CS, Aljurf M, Kindwall-Keller T, Kharfan-Dabaja MA, Hildebrandt GC, Pawarode A, Solh MM, Yared JA, Grunwald MR, Nathan S, Nishihori T, Seo S, Scott BL, Nakamura R, Oran B, Czerw T, Yakoub-Agha I, Saber W

Blood advances.. 2023 August 87 (15):3993-4002. Epub 1900 01 01.

Efferocytosis by bone marrow mesenchymal stromal cells disrupts osteoblastic differentiation via mitochondrial remodeling.

Quarato ER, Salama NA, Li AJ, Smith CO, Zhang J, Kawano Y, McArthur M, Liesveld JL, Becker MW, Elliott MR, Eliseev RA, Calvi LM

Cell death & disease.. 2023 July 1414 (7):428. Epub 07/14/2023.

Adaptation of Serious Illness Care Program to be delivered via telehealth for older patients with hematologic malignancy.

Locastro M, Sanapala C, Mendler JH, Norton SA, Bernacki R, Carroll T, Klepin HD, Watson EE, Liesveld JL, Huselton EJ, O'Dwyer KM, Baran AM, Flannery M, Kluger B, Loh KP

Blood advances.. 2023 May 97 (9):1871-1884. Epub 1900 01 01.

Myelodysplastic syndromes disable human CD271+VCAM1+CD146+ niches supporting normal hematopoietic stem/progenitor cells.

Kawano Y, Kawano H, Ghoneim D, Fountaine TJ, Byun DK, LaMere MW, Mendler JH, Ho T, Salama NA, Myers JR, Hussein SE, Frisch BJ, Ashton JM, Azadniv M, Liesveld JL, Kfoury Y, Scadden DT, Becker MW, Calvi LM

bioRxiv : the preprint server for biology.. 2023 April 28 Epub 04/28/2023.

Dasatinib/prednisone induction followed by blinatumomab/dasatinib in Ph+ acute lymphoblastic leukemia.

Advani AS, Moseley A, O'Dwyer KM, Wood BL, Park JH, Wieduwilt MJ, Jeyakumar D, Yaghmour G, Atallah E, Gerds AT, O'Brien SM, Liesveld JL, Othus M, Litzow MR, Stone RM, Sharon E, Erba HP

Blood advances.. 2023 April 117 (7):1279-1285. Epub 1900 01 01.

Clonal cytopenia of undetermined significance (CCUS)-associated reversion of donor-derived, transient ?? T-cell large granular clonal lymphocytosis, emerging post-transplant in a patient with a history of ?? T-cell large granular lymphocytic leukemia.

El Hussein S, Evans AG, Fitzsimmons JM, Leong N, Buldo M, Segal JP, Jajosky AN, Rothberg PG, Liesveld JL, Oltvai ZN

Cold Spring Harbor molecular case studies.. 2023 April 9 (2)Epub 05/09/2023.

The roles of bone remodeling in normal hematopoiesis and age-related hematological malignancies.

Zhang H, Liesveld JL, Calvi LM, Lipe BC, Xing L, Becker MW, Schwarz EM, Yeh SA

Bone research.. 2023 March 1411 (1):15. Epub 03/14/2023.

Adapting a patient-centered communication tool for older patients with acute myeloid leukemia and their oncologist.

Watson EE, Sanapala C, Cortes AM, Klepin HD, Wittink M, Norton SA, Richardson DR, Dale W, Magnuson A, Mendler JH, Liesveld JL, Huselton EJ, O'Dwyer KM, LeBlanc TW, El-Jawahri A, Wong M, Loh KP

Blood advances.. 2022 November 86 (21):5707-5710. Epub 1900 01 01.

Mast cell leukemia morphologic illustration of a rare entity.

Syposs CR, Evans AG, Bennett JM, Liesveld JL, El Hussein S

EJHaem.. 2022 November 3 (4):1422-1424. Epub 09/09/2022.

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) arising in the setting of polycythemia vera (PV): An illustration of the emerging role of flow cytometry analysis in monitoring progression of myeloproliferative neoplasms.

El Hussein S, Yabe M, Wang W, Pemmaraju N, Loghavi S, Jelloul FZ, Fang H, Medeiros LJ, Burack WR, Evans AG, Liesveld JL, Bennett JM

EJHaem.. 2022 August 3 (3):954-957. Epub 07/03/2022.

A single-arm pilot study of a mobile health exercise intervention (GO-EXCAP) in older patients with myeloid neoplasms.

Loh KP, Sanapala C, Watson EE, Jensen-Battaglia M, Janelsins MC, Klepin HD, Schnall R, Culakova E, Vertino P, Susiarjo M, Lin PJ, Mendler JH, Liesveld JL, Huselton EJ, Taberner K, Mohile SG, Mustian K

Blood advances.. 2022 July 126 (13):3850-3860. Epub 1900 01 01.

Cytopenia after CAR-T Cell Therapy-A Brief Review of a Complex Problem.

Sharma N, Reagan PM, Liesveld JL

Cancers.. 2022 March 1514 (6)Epub 03/15/2022.

Phase 1/2 study of uproleselan added to chemotherapy in patients with relapsed or refractory acute myeloid leukemia.

DeAngelo DJ, Jonas BA, Liesveld JL, Bixby DL, Advani AS, Marlton P, Magnani JL, Thackray HM, Feldman EJ, O'Dwyer ME, Becker PS

Blood.. 2022 February 24139 (8):1135-1146. Epub 1900 01 01.

Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia.

Wieduwilt MJ, Metheny L, Zhang MJ, Wang HL, Estrada-Merly N, Marks DI, Al-Homsi AS, Muffly L, Chao NJ, Rizzieri D, Gale RP, Gadalla SM, Cairo MS, Mussetti A, Gore SD, Bhatt VR, Patel SS, Michelis FV, Inamoto Y, Badawy SM, Copelan E, Palmisiano N, Kharfan-Dabaja MA, Lazarus HM, Ganguly S, Bredeson CN, Diaz Perez MA, Cassaday R, Savani BN, Ballen KK, Martino R, Wirk B, Bacher U, Aljurf M, Bashey A, Murthy HS, Yared JA, Aldoss I, Farhadfar N, Liu H, Abdel-Azim H, Waller EK, Solh M, Seftel M, van der Poel MWM, Grunwald MR, Liesveld JL, Kamble RT, McGuirk JP, Munker R, Cahn JY, Lee JW, Freytes CO, Krem M, Winestone LE, Gergis U, Nathan S, Olsson RF, Verdonck LF, Sharma A, Ringden O, Friend BD, Cerny J, Choe HK, Chhabra S, Nishihori T, Seo S, George B, Baxter-Lowe LA, Hildebrandt GC, de Lima M, Litzow MR, Kebriaei P, Hourigan CS, Abid MB, Weisdorf DJ, Saber W

Blood advances.. 2022 January 116 (1):339-357. Epub 1900 01 01.

A phase II study of sequential decitabine and rapamycin in acute myelogenous leukemia.

Liesveld JL, Baran A, Azadniv M, Misch H, Nedrow K, Becker M, Loh KP, O'Dwyer KM, Mendler JH

Leukemia research.. 2022 January 112 :106749. Epub 11/11/2021.

Portable medical orders and end-of-life measures in acute myeloid leukemia and myelodysplastic syndromes.

Locastro M, Baran A, Liesveld JL, Huselton EJ, Becker MW, O'Dwyer KM, Aljitawi OS, Baumgart M, Snyder E, Kluger B, Loh KP, Mendler JH

Blood advances.. 2021 December 285 (24):5554-5564. Epub 1900 01 01.

Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study.

Cutler CS, Lee SJ, Arai S, Rotta M, Zoghi B, Lazaryan A, Ramakrishnan A, DeFilipp Z, Salhotra A, Chai-Ho W, Mehta RS, Wang T, Arora M, Pusic I, Saad A, Shah NN, Abhyankar S, Bachier C, Galvin JP, Im A, Langston A, Liesveld JL, Juckett M, Logan A, Schachter L, Alavi A, Howard DS, Waksal H, Ryan J, Eiznhamer D, Aggarwal SK, Ieyoub J, Schueller O, Green LS, Yang Z, Krenz H, Jagasia M, Blazar BR, Pavletic SZ

Blood.. 2021 December 2138 (22):2278-2289. Epub 1900 01 01.

Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes.

Oran B, Ahn KW, Fretham C, Beitinjaneh A, Bashey A, Pawarode A, Wirk B, Scott BL, Savani BN, Bredeson C, Weisdorf D, Marks DI, Rizzieri D, Copelan E, Hildebrandt GC, Hale GA, Murthy HS, Lazarus HM, Cerny J, Liesveld JL, Yared JA, Yves-Cahn J, Szer J, Verdonck LF, Aljurf M, van der Poel M, Litzow M, Kalaycio M, Grunwald MR, Diaz MA, Sabloff M, Kharfan-Dabaja MA, Majhail NS, Farhadfar N, Reshef R, Olsson RF, Gale RP, Nakamura R, Seo S, Chhabra S, Hashmi S, Farhan S, Ganguly S, Nathan S, Nishihori T, Jain T, Agrawal V, Bacher U, Popat U, Saber W

Transplantation and cellular therapy.. 2021 November 27 (11):921.e1-921.e10. Epub 08/14/2021.

Correction to: Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation.

Percival ME, Wang HL, Zhang MJ, Saber W, de Lima M, Litzow M, Kebriaei P, Abdel-Azim H, Adekola K, Aljurf M, Bacher U, Badawy SM, Beitinjaneh A, Bejanyan N, Bhatt V, Byrne M, Cahn JY, Castillo P, Chao N, Chhabra S, Copelan E, Cutler C, DeFilipp Z, Dias A, Diaz MA, Estey E, Farhadfar N, Frangoul HA, Freytes CO, Gale RP, Ganguly S, Gowda L, Grunwald M, Hossain N, Kamble RT, Kanakry CG, Kansagra A, Kharfan-Dabaja MA, Krem M, Lazarus HM, Lee JW, Liesveld JL, Lin R, Liu H, McGuirk J, Munker R, Murthy HS, Nathan S, Nishihori T, Olsson RF, Palmisiano N, Passweg JR, Prestidge T, Ringdén O, Rizzieri DA, Rybka WB, Savoie ML, Schultz KR, Seo S, Sharma A, Solh M, Strair R, van der Poel M, Verdonck LF, Yared JA, Weisdorf D, Sandmaier BM

Bone marrow transplantation.. 2021 September 56 (9):2319. Epub 1900 01 01.

Developing and adapting a mobile health exercise intervention for older patients with myeloid neoplasms: A qualitative study.

Loh KP, Sanapala C, Di Giovanni G, Klepin HD, Janelsins M, Schnall R, Culakova E, Vertino P, Susiarjo M, Mendler JH, Liesveld JL, Lin PJ, Dunne RF, Kleckner I, Mustian K, Mohile SG

Journal of geriatric oncology.. 2021 July 12 (6):909-914. Epub 03/04/2021.

Correction: Impact of autologous blood transfusion after bone marrow harvest on unrelated donor's health and outcome: a CIBMTR analysis.

Farhadfar N, Murthy HS, Logan BR, Sees JA, Ayas M, Battiwalla M, Beitinjaneh AM, Chhabra S, Diaz MA, Engles K, Frangoul H, Ganguly S, Gergis U, Kamani NR, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Norkin M, O' Donnell PV, Olsson RF, Rossmann S, Savani BN, Schears R, Seo S, Solh MM, Spitzer T, Sugrue M, Yared JA, Linenberger M, Schwartz J, Pulsipher MA, Shah NN, Switzer GE, Confer DL, Shaw BE, Wingard JR

Bone marrow transplantation.. 2021 February 56 (2):522. Epub 1900 01 01.

Barriers to Hematopoietic Cell Transplantation for Adults in the United States: A Systematic Review with a Focus on Age.

Flannelly C, Tan BE, Tan JL, McHugh CM, Sanapala C, Lagu T, Liesveld JL, Aljitawi O, Becker MW, Mendler JH, Klepin HD, Stock W, Wildes TM, Artz A, Majhail NS, Loh KP

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2020 December 26 (12):2335-2345. Epub 09/20/2020.

Impact of autologous blood transfusion after bone marrow harvest on unrelated donor's health and outcome: a CIBMTR analysis.

Farhadfar N, Murthy HS, Logan BR, Sees JA, Ayas M, Battiwalla M, Beitinjaneh AM, Chhabra S, Diaz MA, Engles K, Frangoul H, Ganguly S, Gergis U, Kamani NR, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Norkin M, O' Donnell PV, Olsson RF, Rossmann S, Savani BN, Schears R, Seo S, Solh MM, Spitzer T, Sugrue M, Yared JA, Linenberger M, Schwartz J, Pulsipher MA, Shah NN, Switzer GE, Confer DL, Shaw BE, Wingard JR

Bone marrow transplantation.. 2020 November 55 (11):2121-2131. Epub 04/30/2020.

Comparison of outcomes of HCT in blast phase of BCR-ABL1- MPN with de novo AML and with AML following MDS.

Gupta V, Kim S, Hu ZH, Liu Y, Aljurf M, Bacher U, Beitinjaneh A, Cahn JY, Cerny J, Copelan E, Gadalla SM, Gale RP, Ganguly S, George B, Gerds AT, Gergis U, Hamilton BK, Hashmi S, Hildebrandt GC, Kamble RT, Kindwall-Keller T, Lazarus HM, Liesveld JL, Litzow M, Maziarz RT, Nishihori T, Olsson RF, Rizzieri D, Savani BN, Seo S, Solh M, Szer J, Verdonck LF, Wirk B, Woolfrey A, Yared JA, Alyea EP, Popat UR, Sobecks RM, Scott BL, Nakamura R, Saber W

Blood advances.. 2020 October 134 (19):4748-4757. Epub 1900 01 01.

Collection of Peripheral Blood Progenitor Cells in 1 Day Is Associated with Decreased Donor Toxicity Compared to 2 Days in Unrelated Donors.

Hsu JW, Shaw BE, Kim S, Logan BR, Sees JA, Confer DL, Pulsipher MA, Shah N, Switzer GE, Abidi MH, Ahmed IA, Anderlini PN, Bredeson C, Chhabra S, Dandoy CE, Diaz MA, Farhadfar N, Ganguly S, Gergis U, Hale GA, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Murthy HS, Olsson RF, Savani BN, Schears R, Seo S, Solh M, Spitzer T, Steinberg A, Sugrue M, Warkentin P, Wingard JR

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2020 June 26 (6):1210-1217. Epub 02/20/2020.

Survival following allogeneic transplant in patients with myelofibrosis.

Gowin K, Ballen K, Ahn KW, Hu ZH, Ali H, Arcasoy MO, Devlin R, Coakley M, Gerds AT, Green M, Gupta V, Hobbs G, Jain T, Kandarpa M, Komrokji R, Kuykendall AT, Luber K, Masarova L, Michaelis LC, Patches S, Pariser AC, Rampal R, Stein B, Talpaz M, Verstovsek S, Wadleigh M, Agrawal V, Aljurf M, Angel Diaz M, Avalos BR, Bacher U, Bashey A, Beitinjaneh AM, Cerny J, Chhabra S, Copelan E, Cutler CS, DeFilipp Z, Gadalla SM, Ganguly S, Grunwald MR, Hashmi SK, Kharfan-Dabaja MA, Kindwall-Keller T, Kröger N, Lazarus HM, Liesveld JL, Litzow MR, Marks DI, Nathan S, Nishihori T, Olsson RF, Pawarode A, Rowe JM, Savani BN, Savoie ML, Seo S, Solh M, Tamari R, Verdonck LF, Yared JA, Alyea E, Popat U, Sobecks R, Scott BL, Nakamura R, Mesa R, Saber W

Blood advances.. 2020 May 124 (9):1965-1973. Epub 1900 01 01.

Improvement in a patient with hypereosinophilic syndrome after initiation of dupilumab treatment.

Wieser JK, Kuehn GJ, Prezzano JC, Cusick EH, Stiegler JD, Scott GA, Liesveld JL, Beck LA

JAAD case reports.. 2020 April 6 (4):292-295. Epub 03/25/2020.

Late effects after ablative allogeneic stem cell transplantation for adolescent and young adult acute myeloid leukemia.

Lee CJ, Kim S, Tecca HR, Bo-Subait S, Phelan R, Brazauskas R, Buchbinder D, Hamilton BK, Battiwalla M, Majhail NS, Lazarus HM, Shaw PJ, Marks DI, Litzow MR, Chhabra S, Inamoto Y, DeFilipp Z, Hildebrandt GC, Olsson RF, Kasow KA, Liesveld JL, Rotz SJ, Badawy SM, Bhatt NS, Yared JA, Page KM, Arellano ML, Kent M, Farhadfar N, Seo S, Hematti P, Freytes CO, Rovó A, Ganguly S, Nathan S, Burns L, Shaw BE, Muffly LS

Blood advances.. 2020 March 244 (6):983-992. Epub 1900 01 01.

Bone marrow mesenchymal stromal cells from acute myelogenous leukemia patients demonstrate adipogenic differentiation propensity with implications for leukemia cell support.

Azadniv M, Myers JR, McMurray HR, Guo N, Rock P, Coppage ML, Ashton J, Becker MW, Calvi LM, Liesveld JL

Leukemia.. 2020 February 34 (2):391-403. Epub 09/06/2019.

The Concentration of Total Nucleated Cells in Harvested Bone Marrow for Transplantation Has Decreased over Time.

Prokopishyn NL, Logan BR, Kiefer DM, Sees JA, Chitphakdithai P, Ahmed IA, Anderlini PN, Beitinjaneh AM, Bredeson C, Cerny J, Chhabra S, Daly A, Diaz MA, Farhadfar N, Frangoul HA, Ganguly S, Gastineau DA, Gergis U, Hale GA, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Murthy HS, Norkin M, Olsson RF, Papari M, Savani BN, Szer J, Waller EK, Wirk B, Yared JA, Pulsipher MA, Shah NN, Switzer GE, O'Donnell PV, Confer DL, Shaw BE

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2019 July 25 (7):1325-1330. Epub 02/02/2019.

Flaming and fanning: The Spectrum of inflammatory influences in myelodysplastic syndromes.

Banerjee T, Calvi LM, Becker MW, Liesveld JL

Blood reviews.. 2019 July 36 :57-69. Epub 04/18/2019.

Aged marrow macrophages expand platelet-biased hematopoietic stem cells via Interleukin1B.

Frisch BJ, Hoffman CM, Latchney SE, LaMere MW, Myers J, Ashton J, Li AJ, Saunders J, Palis J, Perkins AS, McCabe A, Smith JN, McGrath KE, Rivera-Escalera F, McDavid A, Liesveld JL, Korshunov VA, Elliott MR, MacNamara KC, Becker MW, Calvi LM

JCI insight.. 2019 April 185 (10)Epub 04/18/2019.

Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors.

Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, Artz AS, Ball ED, Bayer RL, Bigelow C, Bolwell BJ, Broun ER, Delgado DC, Duckworth K, Dvorak CC, Hahn TE, Haight AE, Hari PN, Hayes-Lattin BM, Jacobsohn DA, Jakubowski AA, Kasow KA, Lazarus HM, Liesveld JL, Linenberger M, Litzow MR, Longo W, Magalhaes-Silverman M, McCarty JM, McGuirk JP, Mori S, Parameswaran V, Prasad VK, Rowley SD, Rybka WB, Sahdev I, Schriber JR, Selby GB, Shaughnessy PJ, Shenoy S, Spitzer T, Tse WT, Uberti JP, Vusirikala M, Waller EK, Weisdorf DJ, Yanik GA, Navarro WH, Horowitz MM, Switzer GE, Confer DL, Shaw BE

Haematologica.. 2019 April 104 (4):844-854. Epub 10/31/2018.

Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study.

Pulsipher MA, Logan BR, Chitphakdithai P, Kiefer DM, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Varni JW, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, Artz AS, Ball ED, Bayer RL, Bigelow C, Bolwell BJ, Broun ER, Bunin NJ, Delgado DC, Duckworth K, Dvorak CC, Hahn TE, Haight AE, Hari PN, Hayes-Lattin BM, Jacobsohn DA, Jakubowski AA, Kasow KA, Lazarus HM, Liesveld JL, Linenberger M, Litzow MR, Longo W, Magalhaes-Silverman M, McCarty JM, McGuirk JP, Mori S, Prasad VK, Rowley SD, Rybka WB, Sahdev I, Schriber JR, Selby GB, Shaughnessy PJ, Shenoy S, Spitzer T, Tse WT, Uberti JP, Vusirikala M, Waller EK, Weisdorf DJ, Yanik GA, Navarro WH, Horowitz MM, Switzer GE, Shaw BE, Confer DL

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2019 April 25 (4):699-711. Epub 11/10/2018.

Broad and Protective Influenza B Virus Neuraminidase Antibodies in Humans after Vaccination and their Clonal Persistence as Plasma Cells.

Piepenbrink MS, Nogales A, Basu M, Fucile CF, Liesveld JL, Keefer MC, Rosenberg AF, Martinez-Sobrido L, Kobie JJ

mBio.. 2019 March 1210 (2)Epub 03/12/2019.

Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203).

Bolaños-Meade J, Reshef R, Fraser R, Fei M, Abhyankar S, Al-Kadhimi Z, Alousi AM, Antin JH, Arai S, Bickett K, Chen YB, Damon LE, Efebera YA, Geller NL, Giralt SA, Hari P, Holtan SG, Horowitz MM, Jacobsohn DA, Jones RJ, Liesveld JL, Logan BR, MacMillan ML, Mielcarek M, Noel P, Pidala J, Porter DL, Pusic I, Sobecks R, Solomon SR, Weisdorf DJ, Wu J, Pasquini MC, Koreth J

The Lancet. Haematology.. 2019 March 6 (3):e132-e143. Epub 1900 01 01.

Novel mHealth App to Deliver Geriatric Assessment-Driven Interventions for Older Adults With Cancer: Pilot Feasibility and Usability Study.

Loh KP, Ramsdale E, Culakova E, Mendler JH, Liesveld JL, O'Dwyer KM, McHugh C, Gilles M, Lloyd T, Goodman M, Klepin HD, Mustian KM, Schnall R, Mohile SG

JMIR cancer.. 2018 October 294 (2):e10296. Epub 10/29/2018.

Concurrent therapy of chronic lymphocytic leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia utilizing CD19-targeted CAR T-cells.

Geyer MB, Manjunath SH, Evans AG, Park JH, Davila ML, Cutler CS, Wang X, Wang Y, Senechal B, Rivière I, Sadelain M, Liesveld JL, Brentjens RJ

Leukemia & lymphoma.. 2018 July 59 (7):1717-1721. Epub 10/18/2017.

Can we incorporate geriatric assessment in the management of acute lymphoblastic leukemia in older adults?

Loh KP, Liesveld JL, O'Dwyer KM

Journal of geriatric oncology.. 2018 July 9 (4):296-301. Epub 04/05/2018.

Allogeneic Hematopoietic Cell Transplantation for Older Adults with Acute Myeloid Leukemia.

Lipof JJ, Loh KP, O'Dwyer K, Liesveld JL

Cancers.. 2018 June 410 (6)Epub 06/04/2018.

Dueling for dual inhibition: Means to enhance effectiveness of PI3K/Akt/mTOR inhibitors in AML.

Herschbein L, Liesveld JL

Blood reviews.. 2018 May 32 (3):235-248. Epub 12/02/2017.

Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34 Yields Are Less.

Stroncek DF, Shaw BE, Logan BR, Kiefer DM, Savani BN, Anderlini P, Bredeson CN, Hematti P, Ganguly S, Diaz MA, Abdel-Azim H, Ahmed I, Maharaj D, Seftel M, Beitinjaneh A, Seo S, Yared JA, Halter J, O'Donnell PV, Hale GA, Defilipp Z, Lazarus H, Liesveld JL, Zhou Z, Munshi P, Olsson RF, Kasow KA, Szer J, Switzer GE, Chitphakdithai P, Shah N, Confer DL, Pulsipher MA

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2018 January 24 (1):175-184. Epub 09/25/2017.

Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in older adults: Current treatment and novel therapies.

O'Dwyer KM, Liesveld JL

Best practice & research. Clinical haematology.. 2017 September 30 (3):184-192. Epub 08/03/2017.

Late Relapses After High-dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Diffuse Large B-cell Lymphoma in the Rituximab Era.

Hunter BD, Herr M, Meacham PJ, Barlaskar F, Evans AG, Burack WR, Liesveld JL, Becker MW, Milner LA, Constine LS, Dhakal S, Barr PM, Friedberg JW, Casulo C

Clinical lymphoma, myeloma & leukemia.. 2017 March 17 (3):145-151. Epub 11/23/2016.

Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR study.

Maziarz RT, Brazauskas R, Chen M, McLeod AA, Martino R, Wingard JR, Aljurf M, Battiwalla M, Dvorak CC, Geroge B, Guinan EC, Hale GA, Lazarus HM, Lee JW, Liesveld JL, Ramanathan M, Reddy V, Savani BN, Smith FO, Strasfeld L, Taplitz RA, Ustun C, Boeckh MJ, Gea-Banacloche J, Lindemans CA, Auletta JJ, Riches ML

Bone marrow transplantation.. 2017 February 52 (2):270-278. Epub 12/19/2016.

Improved outcomes in acute myeloid leukemia patients treated with washed transfusions.

Greener D, Henrichs KF, Liesveld JL, Heal JM, Aquina CT, Phillips GL, Kirkley SA, Milner LA, Refaai MA, Mendler JH, Szydlowski J, Masel D, Schmidt A, Boscoe FP, Schymura MJ, Blumberg N

American journal of hematology.. 2017 January 92 (1):E8-E9. Epub 1900 01 01.

Human SLE bone marrow mesenchymal stem cells (BMSCs) have a senescence-associated secretory phenotype (SASP) mediated by a MAVS-IFN? feedback loop

Liesveld, J.

Arthritis & Rheumatology. 2017; .

Trouble in the niche? Send in a statin.

Liesveld JL

Blood.. 2016 December 22128 (25):2877-2878. Epub 1900 01 01.

Outpatient administration of BEAM conditioning prior to autologous stem cell transplantation for lymphoma is safe, feasible, and cost-effective.

Reid RM, Baran A, Friedberg JW, Phillips GL, Liesveld JL, Becker MW, Wedow L, Barr PM, Milner LA

Cancer medicine. 2016 November 5 (11):3059-3067. Epub 10/03/2016.

Patterns and Timing of Failure for Diffuse Large B-Cell Lymphoma After Initial Therapy in a Cohort Who Underwent Autologous Bone Marrow Transplantation for Relapse.

Dhakal S, Bates JE, Casulo C, Friedberg JW, Becker MW, Liesveld JL, Constine LS

International journal of radiation oncology, biology, physics.. 2016 October 196 (2):372-378. Epub 05/27/2016.

Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis.

Deol A, Sengsayadeth S, Ahn KW, Wang HL, Aljurf M, Antin JH, Battiwalla M, Bornhauser M, Cahn JY, Camitta B, Chen YB, Cutler CS, Gale RP, Ganguly S, Hamadani M, Inamoto Y, Jagasia M, Kamble R, Koreth J, Lazarus HM, Liesveld J, Litzow MR, Marks DI, Nishihori T, Olsson RF, Reshef R, Rowe JM, Saad AA, Sabloff M, Schouten HC, Shea TC, Soiffer RJ, Uy GL, Waller EK, Wiernik PH, Wirk B, Woolfrey AE, Bunjes D, Devine S, de Lima M, Sandmaier BM, Weisdorf D, Khoury HJ, Saber W

Cancer.. 2016 October 122 (19):3005-3014. Epub 06/17/2016.

Evolution of acute myelogenous leukemia stem cell properties after treatment and progression.

Ho TC, LaMere M, Stevens BM, Ashton JM, Myers JR, O'Dwyer KM, Liesveld JL, Mendler JH, Guzman M, Morrissette JD, Zhao J, Wang ES, Wetzler M, Jordan CT, Becker MW

Blood.. 2016 September 29128 (13):1671-8. Epub 07/15/2016.

Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome.

Shaffer BC, Ahn KW, Hu ZH, Nishihori T, Malone AK, Valcárcel D, Grunwald MR, Bacher U, Hamilton B, Kharfan-Dabaja MA, Saad A, Cutler C, Warlick E, Reshef R, Wirk BM, Sabloff M, Fasan O, Gerds A, Marks D, Olsson R, Wood WA, Costa LJ, Miller AM, Cortes J, Daly A, Kindwall-Keller TL, Kamble R, Rizzieri DA, Cahn JY, Gale RP, William B, Litzow M, Wiernik PH, Liesveld J, Savani BN, Vij R, Ustun C, Copelan E, Popat U, Kalaycio M, Maziarz R, Alyea E, Sobecks R, Pavletic S, Tallman M, Saber W

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2016 June 134 (16):1864-71. Epub 04/04/2016.

Phenotypic, genotypic, and functional characterization of normal and acute myeloid leukemia-derived marrow endothelial cells.

Pizzo RJ, Azadniv M, Guo N, Acklin J, Lacagnina K, Coppage M, Liesveld JL

Experimental hematology.. 2016 May 44 (5):378-89. Epub 02/04/2016.

Genetic engineering of platelets to neutralize circulating tumor cells.

Li J, Sharkey CC, Wun B, Liesveld JL, King MR

Journal of controlled release : official journal of the Controlled Release Society.. 2016 April 28228 :38-47. Epub 02/26/2016.

Significant Improvements in the Practice Patterns of Adult Related Donor Care in US Transplantation Centers.

Anthias C, Shaw BE, Kiefer DM, Liesveld JL, Yared J, Kamble RT, D'Souza A, Hematti P, Seftel MD, Norkin M, DeFilipp ZM, Kasow KA, Abidi MH, Savani BN, Shah NN, Anderlini P, Diaz MA, Malone AK, Halter JP, Lazarus HM, Logan BR, Switzer GE, Pulsipher MA, Confer DL, O'Donnell PV

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2016 March 22 (3):520-7. Epub 11/18/2015.

Targeting of the bone marrow microenvironment improves outcome in a murine model of myelodysplastic syndrome.

Balderman SR, Li AJ, Hoffman CM, Frisch BJ, Goodman AN, LaMere MW, Georger MA, Evans AG, Liesveld JL, Becker MW, Calvi LM

Blood.. 2016 February 4127 (5):616-25. Epub 12/04/2015.

Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies.

Pasquini MC, Zhang MJ, Medeiros BC, Armand P, Hu ZH, Nishihori T, Aljurf MD, Akpek G, Cahn JY, Cairo MS, Cerny J, Copelan EA, Deol A, Freytes CO, Gale RP, Ganguly S, George B, Gupta V, Hale GA, Kamble RT, Klumpp TR, Lazarus HM, Luger SM, Liesveld JL, Litzow MR, Marks DI, Martino R, Norkin M, Olsson RF, Oran B, Pawarode A, Pulsipher MA, Ramanathan M, Reshef R, Saad AA, Saber W, Savani BN, Schouten HC, Ringdén O, Tallman MS, Uy GL, Wood WA, Wirk B, Pérez WS, Batiwalla M, Weisdorf DJ

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2016 February 22 (2):248-257. Epub 08/29/2015.

Mixed lineage acute leukemia: navigating the heterogeneity.

Liesveld JL

European journal of haematology.. 2015 November 95 (5):375-6. Epub 05/06/2015.

Evolution to plasmablastic lymphoma evades CD19-directed chimeric antigen receptor T cells.

Evans AG, Rothberg PG, Burack WR, Huntington SF, Porter DL, Friedberg JW, Liesveld JL

British journal of haematology.. 2015 October 171 (2):205-209. Epub 06/18/2015.

Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection Centers.

Shaw BE, Logan BR, Kiefer DM, Chitphakdithai P, Pedersen TL, Abdel-Azim H, Abidi MH, Akpek G, Diaz MA, Artz AS, Dandoy C, Gajewski JL, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Majhail NS, O'Donnell PV, Olsson RF, Savani BN, Schears RM, Stroncek DF, Switzer GE, Williams EP, Wingard JR, Wirk BM, Confer DL, Pulsipher MA

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2015 October 21 (10):1830-8. Epub 06/23/2015.

Plerixafor: potential role in acute leukemia therapy.

Liesveld, JL.

Expert Opinion on Orphan Drugs. 2015; 3(4): 467-475.

Circulating endocannabinoids during hematopoietic stem cell transplantation: A pilot study.

Knight JM, Szabo A, Zhao S, Lyness JM, Sahler OJ, Liesveld JL, Sander T, Rizzo JD, Hillard CJ, Moynihan JA

Neurobiology of stress.. 2015 2 :44-50. Epub 1900 01 01.

Flavaglines target primitive leukemia cells and enhance anti-leukemia drug activity.

Callahan KP, Minhajuddin M, Corbett C, Lagadinou ED, Rossi RM, Grose V, Balys MM, Pan L, Jacob S, Frontier A, Grever MR, Lucas DM, Kinghorn AD, Liesveld JL, Becker MW, Jordan CT

Leukemia.. 2014 October 28 (10):1960-8. Epub 02/28/2014.

Modulation of selectin-mediated adhesion of flowing lymphoma and bone marrow cells by immobilized SDF-1.

Hedges EA, Hughes AD, Liesveld JL, King MR

International journal of molecular sciences.. 2014 August 2715 (9):15061-72. Epub 08/27/2014.

Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease.

Bachanova V, Marks DI, Zhang MJ, Wang H, de Lima M, Aljurf MD, Arellano M, Artz AS, Bacher U, Cahn JY, Chen YB, Copelan EA, Drobyski WR, Gale RP, Greer JP, Gupta V, Hale GA, Kebriaei P, Lazarus HM, Lewis ID, Lewis VA, Liesveld JL, Litzow MR, Loren AW, Miller AM, Norkin M, Oran B, Pidala J, Rowe JM, Savani BN, Saber W, Vij R, Waller EK, Wiernik PH, Weisdorf DJ

Leukemia.. 2014 March 28 (3):658-65. Epub 08/30/2013.

Neutrophil-mediated IFN activation in the bone marrow alters B cell development in human and murine systemic lupus erythematosus.

Palanichamy A, Bauer JW, Yalavarthi S, Meednu N, Barnard J, Owen T, Cistrone C, Bird A, Rabinovich A, Nevarez S, Knight JS, Dedrick R, Rosenberg A, Wei C, Rangel-Moreno J, Liesveld J, Sanz I, Baechler E, Kaplan MJ, Anolik JH

The Journal of immunology : official journal of the American Association of Immunologists.. 2014 February 1192 (3):906-18. Epub 12/30/2013.

Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission.

Warlick SD, Paulson K, Brazauskas R, Zhong X, Miller AM, Camitta BM, George B, Savani BN, Ustun C, Marks DI, Waller EK, Baron F, Freytes CO, Socie G, Akpek G, Schouten HC, Lazarus HM, Horwitz EM, Koreth J, Cahn JY, Bornhauser M, Seftel M, Cairo MS, Laughlin MJ, Sabloff M, Ringdén O, Gale RP, Kamble RT, Vij R, Gergis U, Mathews V, Saber W, Chen YB, Liesveld JL, Cutler CS, Ghobadi A, Uy GL, Eapen M, Weisdorf DJ, Litzow MR

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2014 February 20 (2):202-8. Epub 11/01/2013.

Peri-transplant psychosocial factors and neutrophil recovery following hematopoietic stem cell transplantation.

Knight JM, Moynihan JA, Lyness JM, Xia Y, Tu X, Messing S, Hunter BC, Huang LS, Obi RO, Gaisser D, Liesveld JL, Sahler OJ

PloS one.. 2014 9 (6):e99778. Epub 06/10/2014.

A phase 1 trial of eltrombopag in patients undergoing stem cell transplantation after total body irradiation.

Liesveld JL, Phillips GL, Becker M, Constine LS, Friedberg J, Andolina JR, Milner LA, Debolt J, Smudzin T, Hyrien O, Erickson-Miller CL, Johnson BM, Dawson KL, Chen Y

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2013 December 19 (12):1745-52. Epub 10/08/2013.

A phase I study of decitabine and rapamycin in relapsed/refractory AML.

Liesveld JL, O'Dwyer K, Walker A, Becker MW, Ifthikharuddin JJ, Mulford D, Chen R, Bechelli J, Rosell K, Minhajuddin M, Jordan CT, Phillips GL

Leukemia research.. 2013 December 37 (12):1622-7. Epub 09/08/2013.

Targeting aberrant glutathione metabolism to eradicate human acute myelogenous leukemia cells.

Pei S, Minhajuddin M, Callahan KP, Balys M, Ashton JM, Neering SJ, Lagadinou ED, Corbett C, Ye H, Liesveld JL, O'Dwyer KM, Li Z, Shi L, Greninger P, Settleman J, Benes C, Hagen FK, Munger J, Crooks PA, Becker MW, Jordan CT

The Journal of biological chemistry.. 2013 November 22288 (47):33542-33558. Epub 10/02/2013.

Outcomes and costs of autologous stem cell mobilization with chemotherapy plus G-CSF vs G-CSF alone.

Sung AD, Grima DT, Bernard LM, Brown S, Carrum G, Holmberg L, Horwitz ME, Liesveld JL, Kanda J, McClune B, Shaughnessy P, Tricot GJ, Chao NJ

Bone marrow transplantation.. 2013 November 48 (11):1444-9. Epub 06/10/2013.

Psychosocial factors and hematopoietic stem cell transplantation: potential biobehavioral pathways.

Knight JM, Lyness JM, Sahler OJ, Liesveld JL, Moynihan JA

Psychoneuroendocrinology.. 2013 November 38 (11):2383-93. Epub 07/08/2013.

Providing personalized prognostic information for adult leukemia survivors.

Lee SJ, Storer B, Wang H, Lazarus HM, Waller EK, Isola LM, Klumpp TR, Umejiego JB, Savani BN, Loren AW, Cairo MS, Camitta BM, Cutler CS, George B, Khoury HJ, Marks DI, Rizzieri DA, Copelan EA, Gupta V, Liesveld JL, Litzow MR, Miller AM, Schouten HC, Gale RP, Cahn JY, Weisdorf DJ

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2013 November 19 (11):1600-7. Epub 09/06/2013.

A phase I study using bortezomib with weekly idarubicin for treatment of elderly patients with acute myeloid leukemia.

Howard DS, Liesveld J, Phillips GL, Hayslip J, Weiss H, Jordan CT, Guzman ML

Leukemia research.. 2013 November 37 (11):1502-8. Epub 09/08/2013.

Surrogate end points for long-term outcomes in chronic myeloid leukemia.

Akwaa F, Liesveld J

Leukemia & lymphoma.. 2013 October 54 (10):2103-11. Epub 03/08/2013.

Stem cell enrichment with selectin receptors: mimicking the pH environment of trauma.

Cao TM, Mitchell MJ, Liesveld J, King MR

Sensors.. 2013 September 1713 (9):12516-26. Epub 09/17/2013.

The hematopoietic cell transplantation specific comorbidity index and survival after extracorporeal photopheresis, pentostatin, and reduced dose total body irradiation conditioning prior to allogeneic stem cell transplantation.

Hashmi S, Oliva JL, Liesveld JL, Phillips GL, Milner L, Becker MW

Leukemia research.. 2013 September 37 (9):1052-6. Epub 07/03/2013.

Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer?

Alousi AM, Le-Rademacher J, Saliba RM, Appelbaum FR, Artz A, Benjamin J, Devine SM, Kan F, Laughlin MJ, Lazarus HM, Liesveld J, Perales MA, Maziarz RT, Sabloff M, Waller EK, Eapen M, Champlin RE

Blood.. 2013 March 28121 (13):2567-73. Epub 01/29/2013.

BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells.

Lagadinou ED, Sach A, Callahan K, Rossi RM, Neering SJ, Minhajuddin M, Ashton JM, Pei S, Grose V, O'Dwyer KM, Liesveld JL, Brookes PS, Becker MW, Jordan CT

Cell stem cell.. 2013 March 712 (3):329-41. Epub 01/17/2013.

It's ALL in the liposomes: vincristine gets a new package.

Liesveld J, Asselin B

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2013 February 2031 (6):657-9. Epub 01/14/2013.

Eltrombopag, a thrombopoietin receptor agonist, enhances human umbilical cord blood hematopoietic stem/primitive progenitor cell expansion and promotes multi-lineage hematopoiesis.

Sun H, Tsai Y, Nowak I, Liesveld J, Chen Y

Stem cell research.. 2012 September 9 (2):77-86. Epub 05/14/2012.

Use of eltrombopag, a thrombopoietin receptor agonist, in post-transplantation thrombocytopenia.

Reid R, Bennett JM, Becker M, Chen Y, Milner L, Phillips Ii GL, Liesveld J

American journal of hematology.. 2012 July 87 (7):743-5. Epub 05/10/2012.

Involved field radiation therapy following high dose chemotherapy and autologous stem cell transplant benefits local control and survival in refractory or recurrent Hodgkin lymphoma.

Biswas T, Culakova E, Friedberg JW, Kelly JL, Dhakal S, Liesveld J, Phillips GL, Constine LS

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.. 2012 June 103 (3):367-72. Epub 03/05/2012.

High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab era.

Ban-Hoefen M, Kelly JL, Bernstein SH, Liesveld J, Constine L, Becker M, Milner L, Phillips G, Friedberg JW

Leukemia & lymphoma.. 2012 May 53 (5):830-5. Epub 12/06/2011.

Late relapses following high-dose autologous stem cell transplantation (HD-ASCT) for Hodgkin's lymphoma (HL) in the ABVD therapeutic era.

Keller SF, Kelly JL, Sensenig E, Andreozzi J, Oliva J, Rich L, Constine L, Becker M, Phillips G, Liesveld J, Fisher RI, Bernstein SH, Friedberg JW

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2012 April 18 (4):640-7. Epub 08/24/2011.

Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study.

Armand P, Kim HT, Zhang MJ, Perez WS, Dal Cin PS, Klumpp TR, Waller EK, Litzow MR, Liesveld JL, Lazarus HM, Artz AS, Gupta V, Savani BN, McCarthy PL, Cahn JY, Schouten HC, Finke J, Ball ED, Aljurf MD, Cutler CS, Rowe JM, Antin JH, Isola LM, Di Bartolomeo P, Camitta BM, Miller AM, Cairo MS, Stockerl-Goldstein K, Sierra J, Savoie ML, Halter J, Stiff PJ, Nabhan C, Jakubowski AA, Bunjes DW, Petersdorf EW, Devine SM, Maziarz RT, Bornhauser M, Lewis VA, Marks DI, Bredeson CN, Soiffer RJ, Weisdorf DJ

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2012 February 18 (2):280-8. Epub 07/31/2011.

Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review.

Rauh MJ, Rahman F, Good D, Silverman J, Brennan MK, Dimov N, Liesveld J, Ryan DH, Richard Burack W, Bennett JM

Leukemia research.. 2012 January 36 (1):81-6. Epub 09/03/2011.

Management of AML: Who Do We Really Cure?

Liesveld, J.

Leukemia Research. 2012; 36: 1475-1480.

Intra-arterial methylprednisolone for the management of steroid-refractory acute gastrointestinal and hepatic graft versus host disease.

Milner LA, Becker MW, Bernstein SH, Bruckner L, Friedberg JW, Holland GA, Ifthikharuddin JJ, Liesveld JL, Mathes EJ, Menchel HL, Mullen CA, Sasson T, Phillips GL

American journal of hematology.. 2011 August 86 (8):712-4. Epub 05/31/2011.

Proteasome inhibition in myelodysplastic syndromes and acute myelogenous leukemia cell lines.

Liesveld JL, Rosell KE, Bechelli J, Lu C, Messina P, Mulford D, Ifthikharuddin JJ, Jordan CT, Phillips Ii GL

Cancer investigation.. 2011 August 29 (7):439-50. Epub 1900 01 01.

A Phase I trial: dose escalation of melphalan in the "BEAM" regimen using amifostine cytoprotection.

Phillips GL, Bernstein SH, Liesveld JL, Abboud CN, Becker MW, Constine LS, Ifthikharuddin JJ, Loughner JE, Milner LA, Vesole DH, Friedberg JW

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2011 July 17 (7):1033-42. Epub 11/11/2010.

CML: Defining the efficacy of targeted therapy with the TARGET system.

Liesveld JL

Leukemia research.. 2011 May 35 (5):575-6. Epub 12/28/2010.

The combination of bendamustine, bortezomib, and rituximab for patients with relapsed/refractory indolent and mantle cell non-Hodgkin lymphoma.

Friedberg JW, Vose JM, Kelly JL, Young F, Bernstein SH, Peterson D, Rich L, Blumel S, Proia NK, Liesveld J, Fisher RI, Armitage JO, Grant S, Leonard JP

Blood.. 2011 March 10117 (10):2807-12. Epub 01/14/2011.

Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adults.

Navarro WH, Agovi MA, Logan BR, Ballen K, Bolwell BJ, Frangoul H, Gupta V, Hahn T, Ho VT, Juckett M, Lazarus HM, Litzow MR, Liesveld JL, Moreb JS, Marks DI, McCarthy PL, Pasquini MC, Rizzo JD

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2010 October 16 (10):1442-50. Epub 04/20/2010.

Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilization.

Dugan MJ, Maziarz RT, Bensinger WI, Nademanee A, Liesveld J, Badel K, Dehner C, Gibney C, Bridger G, Calandra G

Bone marrow transplantation.. 2010 January 45 (1):39-47. Epub 06/01/2009.

Obesity does not preclude sage and effective myeloablative hematopoietic cell transplantation for acute myleogenous leukemia (AML) in adults.

Navarro, WH; Agovi, MA; Logan, BR; Ballen, K; Bolwell, BJ; Frangold, H; Gupta, V; Hahn, T; Ho, VT; Juckett, M; Lazarus, HM; Litzow, MR; Liesveld, JL; Moreb, JS; Marks, DI; McCarthy, PL; Paquini, MD; Rizzo, JD.

Biol Blood Marrow Transplant. 2010; 16(10): 1442-50.

A Phase I TRial Dose Escalation of Melphalan in the "BEAM" Regimen Using Amifostine Cytoprotection.

Phillips, GL; Bernstein, SH; Liesveld, JL; Abboud, CN; Becker, MW; Constine, LS; Ifthikharuddin, JJ; Loughner, JE; Milner, LA; Vesole, DH; Friedberg, JW.

Biol Blood Marrow Transplant. 2010; .

Patterns and timing of initial relapse in patients subsequently undergoing transplantation for Hodgkin's lymphoma.

Dhakal S, Biswas T, Liesveld JL, Friedberg JW, Phillips GL, Constine LS

International journal of radiation oncology, biology, physics.. 2009 September 175 (1):188-92. Epub 02/26/2009.

Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy.

Mustjoki S, Ekblom M, Arstila TP, Dybedal I, Epling-Burnette PK, Guilhot F, Hjorth-Hansen H, Höglund M, Kovanen P, Laurinolli T, Liesveld J, Paquette R, Pinilla-Ibarz J, Rauhala A, Shah N, Simonsson B, Sinisalo M, Steegmann JL, Stenke L, Porkka K

Leukemia.. 2009 August 23 (8):1398-405. Epub 03/19/2009.

Phase II study of a TLR-9 agonist (1018 ISS) with rituximab in patients with relapsed or refractory follicular lymphoma.

Friedberg JW, Kelly JL, Neuberg D, Peterson DR, Kutok JL, Salloum R, Brenn T, Fisher DC, Ronan E, Dalton V, Rich L, Marquis D, Sims P, Rothberg PG, Liesveld J, Fisher RI, Coffman R, Mosmann T, Freedman AS

British journal of haematology.. 2009 August 146 (3):282-91. Epub 06/10/2009.

A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas.

Brown JR, Friedberg JW, Feng Y, Scofield S, Phillips K, Dal Cin P, Joyce R, Takvorian RW, Fisher DC, Fisher RI, Liesveld J, Marquis D, Neuberg D, Freedman AS

British journal of haematology.. 2009 June 145 (6):741-8. Epub 03/30/2009.

Delivery of apoptotic signal to rolling cancer cells: a novel biomimetic technique using immobilized TRAIL and E-selectin.

Rana K, Liesveld JL, King MR

Biotechnology and bioengineering.. 2009 April 15102 (6):1692-702. Epub 1900 01 01.

Biomolecular Surfaces for the Capture and Reprogramming of Circulating Tumor Cells.

King, Michael R.; Western, Laura T.; Kuldeepsinh, Rana; Liesveld, Jane L.

Journal of Bionic Engineering. 2009; 6(4): 311-317.

Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML.

Walker AR, Komrokji RS, Ifthikharuddin J, Messina P, Mulford D, Becker M, Friedberg J, Oliva J, Phillips G, Liesveld JL, Abboud C

Leukemia research.. 2008 December 32 (12):1830-6. Epub 06/20/2008.

Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia.

Lee SJ, Kukreja M, Wang T, Giralt SA, Szer J, Arora M, Woolfrey AE, Cervantes F, Champlin RE, Gale RP, Halter J, Keating A, Marks DI, McCarthy PL, Olavarria E, Stadtmauer EA, Abecasis M, Gupta V, Khoury HJ, George B, Hale GA, Liesveld JL, Rizzieri DA, Antin JH, Bolwell BJ, Carabasi MH, Copelan E, Ilhan O, Litzow MR, Schouten HC, Zander AR, Horowitz MM, Maziarz RT

Blood.. 2008 October 15112 (8):3500-7. Epub 07/29/2008.

Bortezomib and gemcitabine in relapsed or refractory Hodgkin's lymphoma.

Mendler JH, Kelly J, Voci S, Marquis D, Rich L, Rossi RM, Bernstein SH, Jordan CT, Liesveld J, Fisher RI, Friedberg JW

Annals of oncology : official journal of the European Society for Medical Oncology. 2008 October 19 (10):1759-64. Epub 05/25/2008.

Mixed chimerism in SCT: conflict or peaceful coexistence?

Liesveld JL, Rothberg PG

Bone marrow transplantation.. 2008 September 42 (5):297-310. Epub 07/28/2008.

Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission.

Marks DI, Pérez WS, He W, Zhang MJ, Bishop MR, Bolwell BJ, Bredeson CN, Copelan EA, Gale RP, Gupta V, Hale GA, Isola LM, Jakubowski AA, Keating A, Klumpp TR, Lazarus HM, Liesveld JL, Maziarz RT, McCarthy PL, Sabloff M, Schiller G, Sierra J, Tallman MS, Waller EK, Wiernik PH, Weisdorf DJ

Blood.. 2008 July 15112 (2):426-34. Epub 04/08/2008.

Rapid method for detection of mutations in the nucleophosmin gene in acute myeloid leukemia.

Laughlin TS, Becker MW, Liesveld JL, Mulford DA, Abboud CN, Brown P, Rothberg PG

The Journal of molecular diagnostics : JMD.. 2008 July 10 (4):338-45. Epub 06/13/2008.

Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data.

Hassane DC, Guzman ML, Corbett C, Li X, Abboud R, Young F, Liesveld JL, Carroll M, Jordan CT

Blood.. 2008 June 15111 (12):5654-62. Epub 02/27/2008.

Platelet transfusion and survival in adults with acute leukemia.

Blumberg N, Heal JM, Liesveld JL, Phillips GL, Rowe JM

Leukemia.. 2008 March 22 (3):631-5. Epub 09/06/2007.

HLA-identical sibling allogeneic transplants versus chemotherapy in acute myelogenous leukemia with t(8;21) in first complete remission: collaborative study between the German AML Intergroup and CIBMTR.

Schlenk RF, Pasquini MC, Pérez WS, Zhang MJ, Krauter J, Antin JH, Bashey A, Bolwell BJ, Büchner T, Cahn JY, Cairo MS, Copelan EA, Cutler CS, Döhner H, Gale RP, Ilhan O, Lazarus HM, Liesveld JL, Litzow MR, Marks DI, Maziarz RT, McCarthy PL, Nimer SD, Sierra J, Tallman MS, Weisdorf DJ, Horowitz MM, Ganser A,

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2008 February 14 (2):187-96. Epub 12/20/2007.

P-Selectin coated microtube for enrichment of CD34+ hematopoietic stem and progenitor cells from human bone marrow.

Narasipura SD, Wojciechowski JC, Charles N, Liesveld JL, King MR

Clinical chemistry.. 2008 January 54 (1):77-85. Epub 11/16/2007.

HLA-identical sibling allogeneic transplants versus chemotherapy in acute myelogenous Leukemia with t(8;21) in first complete remission: collaborative study between the German AML Intergroup and CIBMTR.

Schlenk, RF; Pasquini, MC; Perez, WS; Zhang, MJ; Krauter, J; Antin, JH; Bashey, A; Bolwell, BJ; Buchner, T; Cahn, JY; CAiro, MS; Copelan, EA; Cutler, CS; Dohner, H; Gale, RP; Ilhan, O; Lazarus, HM; Liesveld, JL; Litzow, MR; Marks, DI; Maziarz, RT; McCarthy, PL; Nimer, SD; Sierra, J; Tallman, MS; Weisdorf, DJ; Horowitz, MM; Ganser, A; CIBMTR Acute Leukemia Working Committee.

Bio Blood Marrow Transplant. 2008; 14(2): 187-96.

Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data.

Hassane, DC; Guzman, ML; Corbett, M; Li, X; Abboud, R; :Young, F; Liesveld, JL; Carroll, M; Jordan, CT.

Blood. 2008; .

Unrelated donor tranplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission.

Marks, DI; Pereza, WS; He, W; Zhang, MJ; Bishop, MR; Bolwell, BJ; Bredeson, CN; Copelan, EA; Gale, RP; Gupta, V; Hale, GA; Isola, LM; Jkubowski, AA; Keating A; Klumpp, TR; Lazarus, HM; Liesveld, JL; Maziarz, RT; McCarthy, PL; SAbloff, M; Schiller, G; Sierra, J; Tallman, MS; Waller, EK; Wiernik, PH; Weisdorf, DJ.

Blood. 2008; .

Soft tissue sarcoma in the setting of chronic dutaneous graft versus host disease after allogenic bone marrow tranplantation.

Bylund, KC; Giampoli, E; singh, D; Doerr, T; Sahasrabudhe, D; Liesveld, JL; Constine, LS.

Cancer Invest. 2008; 26(6): 638-41.

Phase I study of cladribine, cytarabine (Ara-C), granylocyte cology stimulating factor (G-CSF) (CLAG regimen) and simultaneous escalating doses of imatinib mseylate (Gleevec) in relapsed/refractory AML.

Walker, AP; Komrokji. RS; Ifthikharuddin, JJ; Messina, P; Mulford, D; Becker, M; Friedberg, J; Oliva, J; Phillips, G; Liesveld, JL; Abboud, C.

Leuk Res. 2008; 32(12): 1830-6.

Mixed chimerism in SCT: conflict or peaceful coexistence?

Liesveld, JL; Rothberg, PG.

Bone Marrow Transplant. 2008; 42(5): 297-310.

Rapid and selective death of leukemia stem and progenitor cells induced by the compound 4-benzyl, 2-methyl, 1,2,4-thiadiazolidine, 3,5 dione (TDZD-8).

Guzman ML, Li X, Corbett CA, Rossi RM, Bushnell T, Liesveld JL, Hébert J, Young F, Jordan CT

Blood.. 2007 December 15110 (13):4436-44. Epub 09/04/2007.

An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells.

Guzman ML, Rossi RM, Neelakantan S, Li X, Corbett CA, Hassane DC, Becker MW, Bennett JM, Sullivan E, Lachowicz JL, Vaughan A, Sweeney CJ, Matthews W, Carroll M, Liesveld JL, Crooks PA, Jordan CT

Blood.. 2007 December 15110 (13):4427-35. Epub 09/05/2007.

Effects of AMD3100 on transmigration and survival of acute myelogenous leukemia cells.

Liesveld JL, Bechelli J, Rosell K, Lu C, Bridger G, Phillips G, Abboud CN

Leukemia research.. 2007 November 31 (11):1553-63. Epub 04/02/2007.

A case of JAK2 positive essential thrombocythemia 16.5 years after autologous marrow transplantation for AML.

Walker AR, Rothberg PG, Liesveld JL

Bone marrow transplantation.. 2007 June 39 (11):725-6. Epub 04/02/2007.

Isodicentric Philadelphia chromosomes in imatinib mesylate (Gleevec)-resistant patients.

Szych CM, Liesveld JL, Iqbal MA, Li L, Siebert S, Asmus C, O'Malley J, Lee A, Wang N

Cancer genetics and cytogenetics.. 2007 April 15174 (2):132-7. Epub 1900 01 01.

A phase 2 study of the farnesyltransferase inhibitor tipifarnib in poor-risk and elderly patients with previously untreated acute myelogenous leukemia.

Lancet JE, Gojo I, Gotlib J, Feldman EJ, Greer J, Liesveld JL, Bruzek LM, Morris L, Park Y, Adjei AA, Kaufmann SH, Garrett-Mayer E, Greenberg PL, Wright JJ, Karp JE

Blood.. 2007 February 15109 (4):1387-94. Epub 11/02/2006.

beta2 Integrins are characteristically absent in acute promyelocytic leukemia and rapidly upregulated in vivo upon differentiation with all-trans retinoic acid.

Wu JJ, Cantor A, Moscinski LC

Leukemia research.. 2007 January 31 (1):49-57. Epub 06/09/2006.

Acute promyelocytic leukemia-mobile and infiltrative.

Liesveld JL

Leukemia research.. 2007 January 31 (1):5-7. Epub 09/15/2006.

Isodicentric Philadelphia chormosomes in imatinib mesylate (Gleevec)-resistant patients.

Szych, CM; Liesveld, JL; Iqbal, MA; Li, L; Sieber, S; Asmus, C; O'Malley, J; Lee, A; Wang, N.

Cancer Genetics Cytogenetics. 2007; 174(2): 132-137.

Effects of AMD3100 on transmigration and survival of acute myelogenous leukemia cells.

Liesveld, JL; Bridger, G; Phillips II, G; Abboud, CN.

Leuk Res. 2007; .

Investigating the feasibility of stem cell enrichment mediated by immobilized selectins.

Charles N, Liesveld JL, King MR

Biotechnology progress.. 2007 23 (6):1463-72. Epub 10/31/2007.

The association of alcohol-induced blackouts and grayouts to blood alcohol concentrations.

Perry PJ, Argo TR, Barnett MJ, Liesveld JL, Liskow B, Hernan JM, Trnka MG, Brabson MA

Journal of forensic sciences.. 2006 July 51 (4):896-9. Epub 1900 01 01.

Apoptosis and complement-mediated lysis of myeloma cells by polyclonal rabbit antithymocyte globulin.

Zand MS, Vo T, Pellegrin T, Felgar R, Liesveld JL, Ifthikharuddin JJ, Abboud CN, Sanz I, Huggins J

Blood.. 2006 April 1107 (7):2895-903. Epub 12/20/2005.

Pretransplantation Consolidation Chemotherapy Decreases Leukemia Relapse after Autologous Blood and Bone Marrow Transplants for Acute Myelogenous Leukemia in First Remission.

Tallman, M; Perez, W; Lazarus, H; Gale, R; Maziarz, R; Rowe, J; Marks, D; Cahn, J; Bashey, A; Bishop, M; Christiansen, N; Frankel, S; Garcia, J; Ilhan, O; Laughlin, M; Liesveld, J; Linker, C; Litzow, M; Weinter, R; Zander, A; Zhang, M; Keating, A; Weisdorf, D; Horowitz, M.

Blood and Marrow Transplantation. 2006; : 204-216.

Platelet transfusion and survival in adults with acute leukemia.

Blumberg, N; Heal, JM; Liesveld, JL; Phillips II, GL; Rowe, JM.

Leukemia. 2006; .

Acute myelogenous leukemia--microenvironment interactions: role of endothelial cells and proteasome inhibition.

Liesveld JL, Rosell KE, Lu C, Bechelli J, Phillips G, Lancet JE, Abboud CN

Hematology.. 2005 December 10 (6):483-94. Epub 1900 01 01.

What would Karl Landsteiner do? The ABO blood group and stem cell transplantation.

Heal JM, Liesveld JL, Phillips GL, Blumberg N

Bone marrow transplantation.. 2005 November 36 (9):747-55. Epub 1900 01 01.

Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States.

Baker KS, Loberiza FR, Yu H, Cairo MS, Bolwell BJ, Bujan-Boza WA, Camitta BM, Garcia JJ, Ho WG, Liesveld JL, Maharaj D, Marks DI, Schultz KR, Wiernik P, Zander AR, Horowitz MM, Keating A, Weisdorf DJ

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2005 October 123 (28):7032-42. Epub 09/06/2005.

The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone.

Flomenberg N, Devine SM, Dipersio JF, Liesveld JL, McCarty JM, Rowley SD, Vesole DH, Badel K, Calandra G

Blood.. 2005 September 1106 (5):1867-74. Epub 05/12/2005.

Polyclonal rabbit antithymocyte globulin triggers B-cell and plasma cell apoptosis by multiple pathways.

Zand MS, Vo T, Huggins J, Felgar R, Liesveld J, Pellegrin T, Bozorgzadeh A, Sanz I, Briggs BJ

Transplantation.. 2005 June 1579 (11):1507-15. Epub 1900 01 01.

Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin.

Horan JT, Liesveld JL, Fenton P, Blumberg N, Walters MC

Bone marrow transplantation.. 2005 January 35 (2):171-7. Epub 1900 01 01.

Phase I study for poor-prognosis lymphoma: augmentation of the "BEAM" regimen with escalating dose melphalan using amifostine cytoprotection and autologous hematopoietic stem cell transplantation--a preliminary report.

Phillips GL, Abboud CN, Bernstein SH, Friedberg JW, Ifthikharuddin JJ, Lancet JE, Liesveld JL, Spreng E, Johnson V, Chapman M, Vesole DH

Seminars in oncology.. 2004 December 31 (6 Suppl 18):59-61. Epub 1900 01 01.

A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome.

Cutler CS, Lee SJ, Greenberg P, Deeg HJ, Pérez WS, Anasetti C, Bolwell BJ, Cairo MS, Gale RP, Klein JP, Lazarus HM, Liesveld JL, McCarthy PL, Milone GA, Rizzo JD, Schultz KR, Trigg ME, Keating A, Weisdorf DJ, Antin JH, Horowitz MM

Blood.. 2004 July 15104 (2):579-85. Epub 03/23/2004.

Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma.

Devine SM, Flomenberg N, Vesole DH, Liesveld J, Weisdorf D, Badel K, Calandra G, DiPersio JF

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2004 March 1522 (6):1095-102. Epub 1900 01 01.

A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group.

Rowe JM, Neuberg D, Friedenberg W, Bennett JM, Paietta E, Makary AZ, Liesveld JL, Abboud CN, Dewald G, Hayes FA, Tallman MS, Wiernik PH,

Blood.. 2004 January 15103 (2):479-85. Epub 09/25/2003.

The hematopoietic stem cell in myelodysplasia.

Liesveld JL, Jordan CT, Phillips GL

Stem cells.. 2004 22 (4):590-9. Epub 1900 01 01.

Effects of the farnesyl transferase inhibitor R115777 on normal and leukemic hematopoiesis.

Liesveld JL, Lancet JE, Rosell KE, Menon A, Lu C, McNair C, Abboud CN, Rosenblatt JD

Leukemia.. 2003 September 17 (9):1806-12. Epub 1900 01 01.

Survival after HLA-identical allogeneic peripheral blood stem cell and bone marrow transplantation for hematologic malignancies: meta-analysis of randomized controlled trials.

Horan JT, Liesveld JL, Fernandez ID, Lyman GH, Phillips GL, Lerner NB, Fisher SG

Bone marrow transplantation.. 2003 August 32 (3):293-8. Epub 1900 01 01.

ABO incompatibility between donor and recipient and clinical outcomes in allogeneic stem cell transplantation.

Goldman J, Liesveld J, Nichols D, Heal J, Blumberg N

Leukemia research.. 2003 June 27 (6):489-91. Epub 1900 01 01.

Flavonoid effects on normal and leukemic cells.

Liesveld JL, Abboud CN, Lu C, McNair C, Menon A, Smith A, Rosell K, Rapoport AP

Leukemia research.. 2003 June 27 (6):517-27. Epub 1900 01 01.

When what you have is not enough: optimizing cord blood transplantation in adults.

Liesveld JL

Leukemia research.. 2003 March 27 (3):197-9. Epub 1900 01 01.

The effect of using music therapy with relaxation imagery in the management of patients undergoing bone marrow transplantation: a pilot feasibility study.

Sahler OJ, Hunter BC, Liesveld JL

Alternative therapies in health and medicine.. 2003 9 (6):70-4. Epub 1900 01 01.

Optimal cytokine stimulation for the enhanced generation of leukemic dendritic cells in short-term culture.

Panoskaltsis N, Belanger TJ, Liesveld JL, Abboud CN

Leukemia research.. 2002 February 26 (2):191-201. Epub 1900 01 01.

Impact of mobilized blood progenitor cell quality determined by the CFU-GM/CD34+ ratio on rapid engraftment after blood stem cell transplantation.

Fu SQ, Abboud CN, Brennan JK, Ifthikharuddin JJ, Nichols D, Liesveld JL

Blood cells, molecules & diseases.. 2002 28 (3):315-21. Epub 1900 01 01.

Oral valacyclovir versus intravenous acyclovir in preventing herpes simplex virus infections in autologous stem cell transplant recipients.

Liesveld JL, Abboud CN, Ifthikharuddin JJ, Lancet JE, Wedow LA, Oliva J, Stamm CG, Nichols D

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2002 8 (12):662-5. Epub 1900 01 01.

Response of human CD34+ cells to CXC, CC, and CX3C chemokines: implications for cell migration and activation.

Liesveld JL, Rosell K, Panoskaltsis N, Belanger T, Harbol A, Abboud CN

Journal of hematotherapy & stem cell research. 2001 October 10 (5):643-55. Epub 1900 01 01.

Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial.

Karp JE, Lancet JE, Kaufmann SH, End DW, Wright JJ, Bol K, Horak I, Tidwell ML, Liesveld J, Kottke TJ, Ange D, Buddharaju L, Gojo I, Highsmith WE, Belly RT, Hohl RJ, Rybak ME, Thibault A, Rosenblatt J

Blood.. 2001 June 197 (11):3361-9. Epub 1900 01 01.

Phase II study of combination human recombinant GM-CSF with intermediate-dose cytarabine and mitoxantrone chemotherapy in patients with high-risk myelodysplastic syndromes (RAEB, RAEBT, and CMML): an Eastern Cooperative Oncology Group Study.

Bennett JM, Young MS, Liesveld JL, Paietta E, Miller KB, Lazarus HM, Marsh RD, Friedenberg WR, Saba HT, Hayes FA, Dewald GW, Hiddemann W, Rowe JM

American journal of hematology.. 2001 January 66 (1):23-7. Epub 1900 01 01.

Mobilization of hematopoietic stem cells.

Fu S, Liesveld J

Blood reviews.. 2000 December 14 (4):205-18. Epub 1900 01 01.

MIP-1alpha and TGF-beta production in CD34+ progenitor-stromal cell coculture systems: effects of progenitor isolation method and cell-cell contact.

Liesveld JL, Harbol AW, Belanger T, Rosell KE, Abboud CN

Blood cells, molecules & diseases.. 2000 August 26 (4):261-75. Epub 1900 01 01.

Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide.

Duerst RE, Horan JT, Liesveld JL, Abboud CN, Zwetsch LM, Senf ES, Constine LS, Raubertas RF, Passarell JA, DiPersio JF

Bone marrow transplantation.. 2000 March 25 (5):489-94. Epub 1900 01 01.

A randomized placebo-controlled trial of lisofylline in HLA-identical, sibling-donor, allogeneic bone marrow transplant recipients. The Lisofylline Marrow Transplant Study Group.

List AF, Maziarz R, Stiff P, Jansen J, Liesveld J, Andrews F, Schuster M, Wolff S, Litzow M, Karanes C, Dahlberg S, Kirkhart B, Bianco JA, Singer JW

Bone marrow transplantation.. 2000 February 25 (3):283-91. Epub 1900 01 01.

Treatment of chronic myelogenous leukemia with autologous bone marrow transplantation followed by roquinimex.

Rowe JM, Rapoport AP, Ryan DH, Nilsson BI, Duerst RE, Packman CH, Abboud CN, DiPersio JF, Linder T, Wang N, Simonsson B, Liesveld JL

Bone marrow transplantation.. 1999 November 24 (10):1057-63. Epub 1900 01 01.

Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic stem-cell transplants.

Rapoport AP, Miller Watelet LF, Linder T, Eberly S, Raubertas RF, Lipp J, Duerst R, Abboud CN, Constine L, Andrews J, Etter MA, Spear L, Powley E, Packman CH, Rowe JM, Schwertschlag U, Bedrosian C, Liesveld JL

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 1999 August 17 (8):2446-53. Epub 1900 01 01.

Effect of nitric oxide production and oxygen tension on progenitor preservation in ex vivo culture.

Reykdal S, Abboud C, Liesveld J

Experimental hematology.. 1999 March 27 (3):441-50. Epub 1900 01 01.

Continuous Infusion Cyclosporine and Nifedipine to Day +100 with Short Methotrexate and Steroids as GVHD Prophylaxis in Unrelated Donor Transplants

Liesveld,J. L.; Duerst,R. E.; Rapoport,A. P.; Constine,L. S.; Abboud,C. N.; Packman,C. H.; Wedow,L. A.; Zwetsch,L.; McKenna,B.; Linder,T.; Silverman,W. A.; Swift,S. B.; Rowe,J. M.; DiPersio,J. F.;.

Bone Marrow Transplants. 1999; 24: 511.

Hematopoietic growth factors and acute leukemia

Rowe, JM; Liesveld, JL.

Cancer Treatment Research. 1999; 99: 195-226.

Hematopoietic growth factors and acute leukemia.

Rowe JM, Liesveld JL

Cancer treatment and research.. 1999 99 :195-226. Epub 1900 01 01.

Infections affecting blood cell morphology.

Phatak PD, Janas JS, Kouides P, Leisveld J, Shafer J, Marder VJ

American journal of hematology.. 1998 November 59 (3):238-41. Epub 1900 01 01.

Autotransplantation for relapsed or refractory Hodgkin's disease: long-term follow-up and analysis of prognostic factors.

Lancet JE, Rapoport AP, Brasacchio R, Eberly S, Raubertas RF, Linder T, Muhs A, Duerst RE, Abboud CN, Packman CH, DiPersio JF, Constine LS, Rowe JM, Liesveld JL

Bone marrow transplantation.. 1998 August 22 (3):265-71. Epub 1900 01 01.

Effect of stromal cell coculture on progenitor cell expansion and myeloid effector function in vitro.

Liesveld JL, Martin BA, Harbol AW, Rosell KE, Belanger TJ, Reykdal SE, Plekavich DL, Abboud CN

Journal of hematotherapy. 1998 April 7 (2):127-39. Epub 1900 01 01.

TGF-beta down-regulates stromal IL-7 secretion and inhibits proliferation of human B cell precursors.

Tang J, Nuccie BL, Ritterman I, Liesveld JL, Abboud CN, Ryan DH

The Journal of immunology : official journal of the American Association of Immunologists.. 1997 July 1159 (1):117-25. Epub 1900 01 01.

Autotransplantation for relapsed or refractory non-Hodgkin's lymphoma (NHL): long-term follow-up and analysis of prognostic factors.

Rapoport AP, Lifton R, Constine LS, Duerst RE, Abboud CN, Liesveld JL, Packman CH, Eberly S, Raubertas RF, Martin BA, Flesher WR, Kouides PA, DiPersio JF, Rowe JM

Bone marrow transplantation.. 1997 May 19 (9):883-90. Epub 1900 01 01.

Hematopoietic growth factors in acute leukemia.

Rowe JM, Liesveld JL

Leukemia.. 1997 March 11 (3):328-41. Epub 1900 01 01.

Expression of interleukin-7 receptor by lineage-negative human bone marrow progenitors with enhanced lymphoid proliferative potential and B-lineage differentiation capacity.

Ryan DH, Nuccie BL, Ritterman I, Liesveld JL, Abboud CN, Insel RA

Blood.. 1997 February 189 (3):929-40. Epub 1900 01 01.

Expression and function of adhesion receptors in acute myelogenous leukemia: parallels with normal erythroid and myeloid progenitors.

Liesveld JL

Acta haematologica.. 1997 97 (1-2):53-62. Epub 1900 01 01.

Stem cell factor and stromal cell co-culture prevent apoptosis in a subculture of the megakaryoblastic cell line, UT-7.

Liesveld JL, Harbol AW, Abboud CN

Leukemia research.. 1996 July 20 (7):591-600. Epub 1900 01 01.

Treatment and prognostic factors in acute myeloid leukaemia.

Rowe JM, Liesveld JL

Baillière's clinical haematology. 1996 March 9 (1):87-105. Epub 1900 01 01.

Patients > or = age 40 years undergoing autologous or allogeneic BMT have regimen-related mortality rates and event-free survivals comparable to patients < age 40 years.

Rapoport AP, DiPersio JF, Martin BA, Duerst RE, Kouides PA, Liesveld JL, Abboud CN, Packman CH, Eberly SW, Sherman M

Bone marrow transplantation.. 1995 April 15 (4):523-30. Epub 1900 01 01.

Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy.

Mauch P, Constine L, Greenberger J, Knospe W, Sullivan J, Liesveld JL, Deeg HJ

International journal of radiation oncology, biology, physics.. 1995 March 3031 (5):1319-39. Epub 1900 01 01.

Effect of stem cell factor on myelopoiesis potential in human Dexter-type culture systems.

Liesveld JL, Broudy VC, Harbol AW, Abboud CN

Experimental hematology.. 1995 March 23 (3):202-9. Epub 1900 01 01.

Characterization of the adherence of normal and leukemic CD34+ cells to endothelial monolayers.

Liesveld JL, Frediani KE, Harbol AW, DiPersio JF, Abboud CN

Leukemia.. 1994 December 8 (12):2111-7. Epub 1900 01 01.

Mechanisms of cytopenia in human immunodeficiency virus infection.

Harbol AW, Liesveld JL, Simpson-Haidaris PJ, Abboud CN

Blood reviews.. 1994 December 8 (4):241-51. Epub 1900 01 01.

CD34+ progenitor cell isolation from blood and marrow: a comparison of techniques for small-scale selection.

Winslow JM, Liesveld JL, Ryan DH, Dipersio JF, Abboud CN

Bone marrow transplantation.. 1994 August 14 (2):265-71. Epub 1900 01 01.

Effects of GM-CSF on Ki67 expression and cell cycle traverse in acute myelogenous leukemia specimens and cell lines.

Liesveld JL, Keng PC, Rowe JM, DiPersio JF, Abboud CN

Leukemia research.. 1994 August 18 (8):609-16. Epub 1900 01 01.

Cytokine regulation of early human lymphopoiesis.

Ryan DH, Nuccie BL, Ritterman I, Liesveld JL, Abboud CN

The Journal of immunology : official journal of the American Association of Immunologists.. 1994 June 1152 (11):5250-8. Epub 1900 01 01.

Integrins and adhesive receptors in normal and leukemic CD34+ progenitor cells: potential regulatory checkpoints for cellular traffic.

Liesveld JL, Dipersio JF, Abboud CN

Leukemia & lymphoma.. 1994 June 14 (1-2):19-28. Epub 1900 01 01.

Integrins and adhesive receptors in normal and leukemic CD34+ progenitor cells: potential regulatory checkpoints for cellular traffic

Liesveld,J. L.; DiPersio,J. F.; Abboud,C. N.;.

Leukemia and Lymphoma. 1994; 18: 19.

Hematopoietic stem cell compartment: Acute and late effects of radiation therapy and chemotherapy San Francisco late effects conference

Mauch, P; Constine, L; Greengerger, J; Knespe, W; Sullivan, J; Liesveld, JL; Deeg, HJ.

Radiation Oncology Biology Physics. 1994; .

One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcome.

Rapoport AP, Rowe JM, Kouides PA, Duerst RA, Abboud CN, Liesveld JL, Packman CH, Eberly S, Sherman M, Tanner MA

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 1993 December 11 (12):2351-61. Epub 1900 01 01.

Autografting in chronic myelogenous leukemia followed by immunotherapy.

Rowe J, Ryan D, Dipersio J, Gaspari A, Nilsson B, Larsson L, Liesveld J, Kouides P, Simonsson B

Stem cells.. 1993 October 11 Suppl 3 :34-42. Epub 1900 01 01.

Phenotypic characterization of the human fibrous histiocytoma giant cell tumor (GCT) cell line and its cytokine repertoire.

Liesveld JL, Rush S, Kempski MC, Turner AR, Brennan JK, Gasson JC, Abboud CN

Experimental hematology.. 1993 September 21 (10):1342-52. Epub 1900 01 01.

Expression of integrins and examination of their adhesive function in normal and leukemic hematopoietic cells.

Liesveld JL, Winslow JM, Frediani KE, Ryan DH, Abboud CN

Blood.. 1993 January 181 (1):112-21. Epub 1900 01 01.

Autografting in chronic myelogenous leukemic followed by immunotherapy

Rowe, J; Ryan, D; DiPersio, J; Gaspari, A; Nilsson, B; Larsson, L; Liesveld, J; Koudies, P; Simonsson, B.

Stem Cells II. 1993; : 34-42.

In vitro erythroid effects of human stem cell factor in a case of human immunodeficiency virus-related chronic parvovirus B19 induced anemia.

Liesveld JL, Weissbach NE, Shafer JA, Abboud CN

Hematologic pathology. 1993 7 (1):23-32. Epub 1900 01 01.

Hypereosinophilic Syndromes: An update

Liesveld, JL; Abboud, CN.

Blood. 1992; 22(5-10).

Hypereosinophilic syndromes: an update.

Liesveld JL, Abboud CN

International journal of clinical & laboratory research. 1992 22 (1):5-10. Epub 1900 01 01.

Cytokine effects and role of adhesive proteins and Fc receptors in human macrophage-mediated antibody dependent cellular cytotoxicity.

Liesveld JL, Frediani KE, Winslow JM, Duerst RE, Abboud CN

Journal of cellular biochemistry.. 1991 April 45 (4):381-90. Epub 1900 01 01.

State of the art; the hypereosinophilic syndromes.

Liesveld JL, Abboud CN

Blood reviews.. 1991 March 5 (1):29-37. Epub 1900 01 01.

Adhesive interactions of normal and leukemic human CD34+ myeloid progenitors: role of marrow stromal, fibroblast, and cytomatrix components.

Liesveld JL, Winslow JM, Kempski MC, Ryan DH, Brennan JK, Abboud CN

Experimental hematology.. 1991 January 19 (1):63-70. Epub 1900 01 01.

Myasthenic (Eaton-Lambert) syndrome in association with an indolent non-Hodgkin's lymphoma.

Liesveld JL, Stern A, Rosenthal SN

New York state journal of medicine.. 1991 January 91 (1):29-30. Epub 1900 01 01.

State of the art: The hypereosinophilic syndromes

Liesveld, JL; Abboud, CN.

Blood. 1991; 5: 29-37.

Treatment patterns in low-grade non-Hodgkin's lymphomas: a single institution study.

Liesveld JL, Raubertas RF, Bennett JM

Medical and pediatric oncology.. 1991 19 (1):1-7. Epub 1900 01 01.

Maturation-dependent adhesion of human B cell precursors to the bone marrow microenvironment.

Ryan DH, Nuccie BL, Abboud CN, Liesveld JL

The Journal of immunology : official journal of the American Association of Immunologists.. 1990 July 15145 (2):477-84. Epub 1900 01 01.

Characterization of human marrow stromal cells: role in progenitor cell binding and granulopoiesis.

Liesveld JL, Abboud CN, Duerst RE, Ryan DH, Brennan JK, Lichtman MA

Blood.. 1989 May 1573 (7):1794-800. Epub 1900 01 01.

Effect of hydrocortisone and interleukins 1 and 2 on eosinophil progenitors in hypereosinophilic states.

Liesveld JL, Abboud CN, Slovick FT, Rowe JM, Brennan JK

International journal of cell cloning.. 1988 November 6 (6):404-16. Epub 1900 01 01.

Expression of IgG Fc receptors in myeloid leukemic cell lines. Effect of colony-stimulating factors and cytokines.

Liesveld JL, Abboud CN, Looney RJ, Ryan DH, Brennan JK

The Journal of immunology : official journal of the American Association of Immunologists.. 1988 March 1140 (5):1527-33. Epub 1900 01 01.

Variability of the erythropoietic response in autoimmune hemolytic anemia: analysis of 109 cases.

Liesveld JL, Rowe JM, Lichtman MA

Blood.. 1987 March 69 (3):820-6. Epub 1900 01 01.

Lysis of human fibroblast colony-forming cells and endothelial cells by monoclonal antibody (6-19) and complement.

Abboud CN, Duerst RE, Frantz CN, Ryan DH, Liesveld JL, Brennan JK

Blood.. 1986 December 68 (6):1196-200. Epub 1900 01 01.

The relative distribution of coronary blood flow in rats with moderate and marked left ventricular hypertrophy

Tomanek,R. J.; Liesveld,J. L.; Laughlin,M. H.; Wangler,R. D.; Wilson,N. C.;.

Cancer Journal of Physiology and Pharmacy. 1980; 58: 830.

Books

In: Encyclopedia of Cancer (2017)

Chapter: Stem Cell Mobilization

Authors: Liesveld, JL

Publisher: Springer-Verlag 2017

In: Williams Hematology (2016)

Chapter: Chronic Myelogenous Leukemia and Related Disorders

Authors: Liesveld, JL and Lichtman, MA

Publisher: McGraw Hill, New York, NY 2016

In: Williams Hematology (2016)

Chapter: Acute Myelogenous Leukemia

Authors: Liesveld, JL and Lichtman, MA

Publisher: McGraw Hill, New York, NY 2016

B-ALERT volume II, The Biocontinuum of Adverse Late Effects of Cancer Treatment" (2011)

Chapter: Hematopoietic System

Authors: Liesveld JL, Rubin P, and Constine LS

Publisher: Springer 2011

Williams Hematology (2010)

Chapter: Myelodysplastic Syndromes(Clonal Cytopenias adn Olgoblastic Muyelogenous Leukemia)

Authors: Liesveld JL and Lichtman MA

Publisher: McGraw-Hill Medical, New York 2010

Williams Hematology (2010)

Chapter: Acute Myelogenous Leukemia

Authors: Liesveld JL and Lichtman MA

Publisher: McGraw-Hill Medical, New York 2010

Williams Hematology (2010)

Chapter: Chronic Myelogenous Leukemia

Authors: Liesveld JL and Lichtman MA

Publisher: McGraw-Hill Medical, New York 2010

Williams Hematology, Seventh Edition (2006)

Chapter: Myelodysplastic syndromes (clonal cytopenias an doligobalstic leukemia)

Authors: Lichtman, MA; Liesveld, JL

Publisher: McGraw-Hill Medical, New York, NY 2006

Williams Hematology, seventh edition (2006)

Chapter: Acute myelogenous leukemis INH

Authors: Liesveld, JL; Lichtman, MA

Publisher: McGraw-Hill Medical, New York, NY 2006

Williams Hematology, Seventh Edition (2006)

Chapter: Chronic myelogenous leukemia and related disorders

Authors: Lichtman, MA; Liesveld, JL

Publisher: McGraw-Hill Medical, New York, NY 2006

Williams Hematology: fifth edition (2001)

Chapter: Chronic Myelogenous Leukemia

Authors: Lichtman, MA; Liesveld, JL

Publisher: McGraw-Hill 2001

Hematology: Basic Principles and Practice (1999)

Chapter: Granulopoiesis and Monocytopoiesis

Authors: Abboud, CN; Liesveld, JL

Publisher: Churchill Livingstone 1999

Diagnostic and Therapeutic Advances in Hematologic Malignancies (1998)

Chapter: Hematopoietic growth factors in acute myelogenous leukemia

Authors: Rowe, JM; Liesveld, JL

Publisher: Kluwer Acedemic Publishers 1998

Medical Management of Hematological Malignant Diseases (1998)

Chapter: Use of hematopoietic growth factors in hematological malignancies

Authors: Rowe, JM; Rapoport, AP; Liesveld, JL

Publisher: Marcel Dekker 1998

7th International Symposium on Autologous Bone Marrow Transplantation (1995)

Chapter: Chronic myelogenous leukemia treated with bone marrow transplantation followed by immunotherapy

Authors: Rowe, JM; Ryan, DH; Nilsson, BI; Liesveld, JL; DiPersio, JF; Larsson, L; Abboud, CN; Packman, CH; Rapoport, AP; Duerst, R; Simonsson, B

Publisher: Cancer Treatment Research Education Funds, Arlington, TX 1995

Advances in Blood Disorders (1995)

Chapter: Clinical Features in: Diagnosis and treatment of acute leukemia in adults

Authors: Liesveld, JL

Publisher: Harwood Acedemic Publishers 1995

Advances in Blood Disorders (1995)

Chapter: Acute Myelogenous Leukemia in: Diagnosis and treatment of acute leukemia in adults

Authors: Liesveld, JL

Publisher: Harwood Acedemic Publishers 1995

Advances in Blood Disorders (1995)

Chapter: Supportive Care in: Diagnosis and treatment of acute leukemia in adults

Authors: Liesveld, JL

Publisher: Harwood Acedemic Publishers 1995

Hematology: Basic Principles and Practice (1994)

Chapter: Granulopoiesis and Monocytopoiesis

Authors: Abboud, CN; Liesveld, JL

Publisher: Churchill Livingstone 1994

Medical Care of the Cancer Patient (1993)

Chapter: Marrow Transplants

Authors: Liesveld, JL

Publisher: WD Saunders, Co 1993

The Hematopoietic Microenvironment (1993)

Chapter: Architecture of Marrow: Role in hemopoietic cell lodgement

Authors: Abboud, CN; Liesveld, JL; Lichtman, MA

Publisher: The Johns Hopkins University Press, Baltimore, MD 1993

Molecular Biology of Hematopoiesis (1992)

Chapter: Characterization of the human mesenchymal GCT cell line: a model for stromal hematopoietic interactions

Authors: Abboud, CN; Rush, S; Landesberg, R; Gasson, JC; Liesveld, JL

Publisher: Intercept Ltd, Andover, UK 1992

Hematopoiesis (1990)

Chapter: Quantitation of the binding of human CD34+ myeloid progenitors to marrow stroma, fibroblasts, and components of the extracellular matrix

Authors: Liesveld, JL; Ryan, DH; Kempski, MC; Brennan, JK; Abboud, CN

Publisher: Alan R. Liss, New York 1990

Ratings & Comments

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.

Ratings

During this visit, did this provider spend enough time with you?

5.0 stars

During this visit, did this provider show respect for what you had to say?

5.0 stars

During this visit did this provider give you easy to understand information about these health questions or concerns?

4.9 stars

During this visit, did this provider listen carefully to you?

5.0 stars

During this visit, did this provider explain things in a way that was easy to understand?

5.0 stars

Patient Comments

My provider showed great concern about my difficulty in getting an appointment (since April) at the UR eye service to follow up on findings from my recent hospitalization. She entered another referral, and the eye service called me the next day to set up my first appointment! Thank you!

Aug 10, 2024

Dr Liesveld is kind, respectful and trustworthy.

Aug 10, 2024

I was extremely taken care of. I had a new to me hemotology doc look me over first and then my reg. Doc. And then both had consultation, with me. They did not miss anything. I feel I really got my monies worth left there a happy person.

Aug 05, 2024

Very good

Jul 20, 2024

5.0 stars

The entire BMT team is always a welcoming visit with care & compassion. Top notch!

May 18, 2024

Dr. Liesveld is always thorough and informative and answers all my questions.

May 09, 2024

5.0 stars

Dr. Liesveld is the best! I am so thankful that she is my healthcare provider.

May 06, 2024

Dr. Jane Liesveld is an important asset to your facility!!!

May 04, 2024

5.0 stars

She's well educated and is a master in her Specialty.

Apr 22, 2024

5.0 stars

Dr. Liesveld is very responsive to my challenging medical condition. She has taught me as a patient to understand my body and know when a medical issue I am having may become a bigger medical issue. Because of that, I am usually able to be treated in a way that my condition does not become critical.

Apr 21, 2024

Dr. Liesveld is a wonderful doctor.

Mar 21, 2024

5.0

Dr Liesveld is excellent, including her team- very respectful and comforting to meet my needs

Mar 12, 2024

I love Dr. Liesveld...she is very knowledgeable, respectful and compassionate!

Feb 11, 2024

5.0

Dr. Liesveld is one of the most compassionate, detailed and experienced Doctors I have had the pleasure to work with. She is focused on me, the patient and has implemented very effective medical treatment plans to help me feel better.

Feb 11, 2024

2.2

I'm an MD, so communication was fine for me. [...] Very shy, poor eye contact, always in a rush. Again, I know, like and respect Dr. Liesveld [...]

Jan 09, 2024

Dr. Liesveld is a wonderful doctor who treats my LGL Leukemia. I have other disorders and she is helpful sorting them out by connecting with my other specialists.

Dec 31, 2023

5.0

Dr. Liesveld is knowledgeable, kind, respectable, empathetic, She has kept me alive for 5 years. This woman has seen me during my highs and my lows. She is my ROCK! Always steady, calm, In control and reassuring. If more doctors were like her people wouldn't be so afraid of medical intervention.

Dec 30, 2023

LOVE LOVE LOVE Dr J. Liesveld

Nov 23, 2023

5.0

Wonderful, compassionate woman

Nov 10, 2023

5.0

Dr. Liesveld has provided exceptional care having found cancer and a GI problem. She focused in on the symptoms in a way my primary providers [...] should have. She is an exceptional specialist.

Nov 09, 2023

5.0

I have a rare bone marrow cancer and options are limited but I am doing well and feel that Dr. Liesveld understands my thoughts and the disease itself.

Jul 13, 2023

5.0

Excellent care

May 25, 2023

5.0

Thank you for always treating me as though I was your only patient, and for saving my life.

May 21, 2023

5.0

Dr. Liesveld is great. Dr. McQuire is too! They are very caring, compassionate, knowledgeable and patient.

May 08, 2023

It was great to have an honest conversation [...]

Feb 06, 2023

5.0

Great experience

Jan 16, 2023

5.0

She is an expect in her field of the work.Very smart and knowledgeable.

Jan 15, 2023

5.0

Dr. Liesveld is a superb communicator. She explained the upcoming treatment in a way I could fully understand. She was very flexible and willing to adjust the plan of care according to my wishes. I felt like we were partners in developing the plan.

Dec 31, 2022

5.0

I left, the visit positive that I was given all the information I needed.

Dec 21, 2022

5.0

Very impressed with doctor. Right to the point. No sugar coating.

Nov 28, 2022

5.0

Excellent care from this provider. She is in the top of her field in expertise and ability to connect with patients.

Nov 24, 2022

5.0

Dr. Liesveld & staff are #1.

Oct 28, 2022

5.0

She is very experienced and knowledgeable about what she's doing.

Oct 16, 2022

5.0

Good.

Sep 15, 2022

5.0

I love my Doctor, she's so compassionate about and with her patients.

Aug 28, 2022

5.0

Jane is excellent. Caring and concerned.

Aug 18, 2022

5.0

Dr. Liesveld is one of the brightest and most caring doctors I have had the pleasure of being treated by. She listens well and always tries to help in any way she can. She treats me like a family member.

Aug 05, 2022

5.0

She is a gifted dr.

Jul 31, 2022

5.0

During every visit with The DR. She always ask me if I have any questions or concerns, that I would like to ask, or shared with her.

Jul 22, 2022

5.0

Dr. Liesveld always responds thoroughly to my questions and does not "dumb down" her responses as some doctors do.

Jul 17, 2022

5.0

She very kind nice person ask question and listen [...].

Jun 17, 2022

5.0

Excellent care!!!

May 24, 2022

5.0

I feel well-cared for/followed by Dr Liesveld and her NP, Kelly Likely.

May 16, 2022

5.0

Dr. Liesveld is OUTSTANDING!

Apr 16, 2022

5.0

Extremely pleased in every respect with this provider and staff.

Apr 07, 2022

5.0

Dr. Liesveld discussed all my treatment options.

Mar 28, 2022

5.0

Took all time I needed, answered all my questions. Gave me all my options.

Feb 21, 2022

The doctor said I have on my team are absolutely wonderful and I would recommend them to anyone I have been so blessed

Feb 12, 2022

Dr. Liesveld is the best in her field. She is thorough and efficient. I trust her completely. Her nurse Shelby Is wonderful as well.

Feb 10, 2022